SAUDI ARABIA

Saudi Drug Authority, China’s National Medical Products Administration sign MoU for regulatory collaboration

November 01, 2024
The agreement was signed in Beijing.
The agreement was signed in Beijing.

BEIJING — The Saudi Food and Drug Authority (SFDA) signed a Memorandum of Understanding (MoU) on Friday with China’s National Medical Products Administration (NMPA) in Beijing, aiming to enhance cooperation in regulatory matters.

The agreement was signed by SFDA's CEO Dr. Hisham Aljadhey and NMPA Commissioner Li Li, with Saudi Arabia’s Ambassador to China, Abdulrahman Al-Harbi, in attendance.

The MoU focuses on sharing regulatory information related to medicines, medical devices, and cosmetics, covering laws, regulations, and best practices. This partnership highlights the SFDA’s commitment to bolstering international cooperation through strategic alliances.

This agreement coincides with Dr. Aljadhey’s visit to China, where he will lead the Saudi delegation at the 8th Shenzhen Food Safety Forum, scheduled for November 5-6, 2024. — SG


November 01, 2024
200 views
HIGHLIGHTS
SAUDI ARABIA
6 hours ago

Crown Prince holds high-level meetings with global leaders during One Water Summit

SAUDI ARABIA
7 hours ago

NEOM green hydrogen project to supply 10% of global demand, Alkhorayef says

SAUDI ARABIA
8 hours ago

Saudi, French energy ministers explore opportunities for investment and collaboration in key sectors